video Video: Sino Biological: the global leader in recombinant technology 24 June 2021 | By Sino Biological Inc. Sino Biological is an international reagent supplier and service provider. The company specialises in recombinant protein production and antibody development.
whitepaper Catalogue: Resources for COVID-19 and influenza vaccine development 18 June 2021 | By Sino Biological Inc. A panel of SARS-CoV-2 reagents (e.g. antigens, antibodies, and kits) and influenza antigens have been developed to support the development of vaccines.
whitepaper Catalogue: Cytokines and growth factors from Sino Biological 13 May 2021 | By Sino Biological Inc. Sino Biological has developed 1,000+ cytokines and receptors, including growth factors, cytokines, chemokines, interferons, interleukins, etc.
whitepaper Catalogue: Drug target reagents 20 April 2021 | By Sino Biological Inc. 5,000+ drug target reagents for antibody, small molecule drug discovery and development, including immune checkpoints, cytokines and kinases.
whitepaper Resource library: Reagent resource for studying SARS-CoV-2 variants 23 February 2021 | By Sino Biological Inc. Sino Biological has developed 80+ mutant proteins covering the newest mutations identified in SARS-CoV-2 variants, such as UK's B.1.1.7, Brazil's P.1.
